Emergent BioSolutions Insider Trades
NYSE: EBSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 6.98 -1.13%
Last 12 months
- Purchases
- 0 · $0
- Sales
- 1 · $126.20K
- Shares bought / sold
- 0 / 17.80K
- Net activity
- Net selling $126,202
Emergent BioSolutions insider activity
Over the last 12 months, Emergent BioSolutions insiders reported 1 transaction on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $126,202 worth of stock, for net insider selling of $126,202. The largest seller was DeGolyer Donald W, with $126,202 in reported sales.
The most recent filing shows DeGolyer Donald W (Director) selling 17,800 shares at $7.09 on Oct 7, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put EBS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
EBS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 7, 2026 | DeGolyer Donald WDirector | Sale | 17,800 | $126.20K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4